I now have comprehensive data. Let me compile the detailed note.
Detailed Note: End Game Strategy of TB & End TB Strategy
Context: Community Medicine / Preventive & Social Medicine
1. Introduction and the Need for a Paradigm Shift
Tuberculosis remains the world's deadliest infectious disease measured by annual deaths. It claims approximately 3 lives every minute. Of the ~9 million people who fall ill with TB each year, more than 3 million are not diagnosed, treated, or officially registered by national TB programmes - collectively termed the "missed millions." Each undiagnosed and untreated individual can infect up to 15 people per year, making TB a massive public health failure.
TB is not purely a biomedical problem. It is deeply entangled with poverty, undernutrition, migration, ageing populations, and risk factors like diabetes, silicosis, and smoking. The global resolve to end the TB epidemic reached a milestone when:
- WHO's End TB Strategy was adopted by the World Health Assembly (WHA) in 2014
- "Ending the TB epidemic" was included as a target in Sustainable Development Goal 3 (SDG-3) by the UN General Assembly in September 2015
(Park's Textbook of Preventive and Social Medicine, p. 237)
2. Evolution of Global TB Strategies
| Strategy | Period | Key Focus |
|---|
| DOTS Strategy | 1994-2005 | Government commitment, passive case finding, standardized short-course chemotherapy, drug supply, monitoring |
| Stop TB Strategy | 2006-2015 | HIV-TB, MDR-TB, engaging public-private providers, civil society, research investment |
| End TB Strategy | 2016-2035 | Holistic mix of health, social interventions; universal access; prevention; new tools |
Through DOTS and Stop TB, 43 million lives were saved globally between 2000-2014 and the MDG target of halting and reversing the TB epidemic was met. However, incidence rates did not fall sharply enough - demonstrating that treatment alone is insufficient to end the epidemic.
(Park's, p. 237-238)
3. The End TB Strategy (2016-2035)
3.1 Vision and Goal
| |
|---|
| Vision | A world free of tuberculosis - zero deaths, zero disease, zero suffering due to tuberculosis |
| Goal | End the global tuberculosis epidemic by 2035 |
3.2 Indicators, Milestones & Targets
| Indicator | 2020 Milestone | 2025 Milestone | SDG 2030 Target | End TB 2035 Target |
|---|
| Reduction in TB deaths (vs 2015) | 35% | 75% | 90% | 95% |
| Reduction in TB incidence rate (vs 2015) | 20% (<85/100,000) | 50% (<55/100,000) | 80% (<20/100,000) | 90% (<10/100,000) |
| TB-affected families facing catastrophic costs | 0% | 0% | 0% | 0% |
Key Note: TB elimination is defined as <1 case per million population - this is the long-term vision beyond 2035.
(Park's, p. 238; WHO End TB Strategy; PAHO Essentials Document)
4. Four Principles of the End TB Strategy
- Government stewardship and accountability, with monitoring and evaluation
- Strong coalition with civil society organizations and communities
- Protection and promotion of human rights, ethics and equity
- Adaptation of the strategy and targets at country level, with global collaboration
(Park's, p. 238)
5. Three Pillars and Ten Components of the End TB Strategy
PILLAR 1: Integrated, Patient-Centred Care and Prevention
- Early diagnosis of TB including universal drug susceptibility testing (DST); systematic screening of contacts and high-risk groups
- Treatment of all people with TB including drug-resistant TB; patient support
- Collaborative TB/HIV activities and management of comorbidities
- Preventive treatment of persons at high risk; vaccination against TB (BCG)
PILLAR 2: Bold Policies and Supportive Systems
- Political commitment with adequate resources for TB care and prevention
- Engagement of communities, civil society organizations, and public and private care providers
- Universal health coverage policy and regulatory frameworks for case notification, vital registration, quality and rational use of medicines, and infection control
- Social protection, poverty alleviation, and action on other determinants of TB
PILLAR 3: Intensified Research and Innovation
- Discovery, development, and rapid uptake of new tools, interventions, and strategies
- Research to optimize implementation and impact, and promote innovations
(Park's, p. 238; WHO End TB Strategy)
6. Four Barriers Identified by the End TB Strategy
The strategy explicitly identifies four key barriers to progress:
- Weak health systems
- Underlying determinants of TB - poverty, undernutrition, migration, ageing population; and risk factors such as diabetes, silicosis, and smoking
- Lack of effective tools (point-of-care diagnostics, shorter regimens, effective vaccine)
- Continuous unmet funding needs
(Park's, p. 238)
7. What Is Needed to Reach 2030 and 2035 Targets?
According to the WHO "End TB Essentials" document, achieving the 2030-2035 targets requires:
- Achievement of all 2025 milestones first
- Around 2025, availability of new tools that can substantially reduce risk of active TB among those with latent TB infection (LTBI) - including:
- An effective post-exposure vaccine (prevents TB disease in already-infected individuals)
- A safer and more effective treatment for LTBI
- Better LTBI diagnostic tests
- After 2025, the TB incidence rate must fall at an average of 17% per year to hit the 2035 target
- Greatly expanded investment in research and development
This is where the concept of the "endgame" for TB becomes relevant - just as the Polio Endgame Strategy required targeted interventions for the final phase of eradication, TB requires a phased intensification with new tools.
8. The "Endgame" Concept in TB - Community Medicine Perspective
The term "endgame" in TB control refers to the final phase of elimination efforts where standard control measures alone are insufficient and targeted, high-impact interventions are needed to cross the last epidemiological threshold.
Key Endgame Interventions:
| Domain | Endgame Intervention |
|---|
| Diagnosis | Universal DST, rapid molecular diagnostics (CBNAAT/GeneXpert), AI-assisted CXR screening |
| Treatment | Shorter all-oral MDR-TB regimens, Bedaquiline-containing regimens |
| Preventive Treatment (TPT) | Treatment of LTBI in household contacts, PLHIV, high-risk populations |
| Community Engagement | Active case finding (ACF) in tribal areas, slums, prisons, orphanages, old-age homes |
| Vaccines | BCG for children; research into post-exposure vaccines (M72/AS01E candidate) |
| Social protection | Nutritional support (Ni-kshay Poshan Yojana - Rs 500/month), transport allowance |
| Digital surveillance | Nikshay platform for real-time case notification and treatment monitoring |
| Private sector | Mandatory notification, engagement under NSP, support for adherence |
9. India's Response - National Tuberculosis Elimination Programme (NTEP)
Background
India accounts for approximately 26% of the global TB burden. The programme was renamed from RNTCP (Revised National Tuberculosis Control Programme) to NTEP (National Tuberculosis Elimination Programme) in view of the End TB targets - signifying the shift from "control" to "elimination."
India's Ambitious Target
India aims to eliminate TB by 2025 - five years ahead of the global SDG 2030 target. This is a bold political commitment requiring accelerated decline of >10-15% annually.
(Park's, p. 482, 488)
NTEP Organogram (5 Levels)
- National level - Central TB Division (CTD), under AS&DG (RNTCP & NACO)
- Supported by NTI Bengaluru, 6 National Reference Laboratories (NRL): NTI, NIRT Chennai, NITRD Delhi, JALMA Agra, RMRC Bhubaneswar, BMHRC Bhopal
- State level - State TB Cell (STC), State TB Officer (STO) under NHM
- District level - District TB Centre (DTC), District TB Officer (DTO)
- Sub-district level - TB Units (TU)
- Peripheral Health Institutions (PHI) - health facilities with at least one medical officer (PHCs, CHCs, dispensaries, referral hospitals)
(Park's, p. 482-483)
10. National Strategic Plan (NSP) 2017-2025 for TB Elimination
The NSP 2017-2025 builds on previous NSPs. It is a 3-year costed plan and 8-year strategic document.
Vision: TB-Free India with zero deaths, disease and poverty due to TB
Four Objectives (NSP):
- Find all DS-TB and DR-TB cases, with emphasis on private sector and high-risk populations
- Initiate and sustain all patients on appropriate treatment with patient-friendly systems and social support
- Prevent emergence of TB in susceptible populations
- Build and strengthen enabling policies, empowered institutions, human resources, and financial resources
Four Strategic Pillars of India's NSP - DTPB Framework:
| Pillar | Full Form | Key Actions |
|---|
| D | Detect | Universal DST, CBNAAT scale-up, active case finding, private sector engagement |
| T | Treat | All-oral regimens, Bedaquiline, Delamanid, patient-wise drug boxes, Nikshay |
| P | Prevent | TB Preventive Treatment (TPT), BCG, infection control, nutrition (Ni-kshay Poshan Yojana) |
| B | Build | Health systems strengthening, HR capacity, digital tools, multi-sectoral partnerships |
(Park's, p. 488)
NSP Targets for 2025 (India):
- 80% reduction in TB incidence (from 211 per lakh to 43 per lakh)
- 90% reduction in TB mortality (from 32 per lakh to 3 per lakh)
- 0% patients with catastrophic expenditure due to TB
Key Strategies under NSP:
- Private sector engagement
- Active case finding (ACF)
- Drug-resistant TB case management
- Addressing social determinants including nutrition
- Robust surveillance (Nikshay system)
- Community engagement and multi-sectoral approach
11. Key Programme Components in the Endgame Phase
a) TB Preventive Treatment (TPT)
Three major interventions available:
- TB Preventive Treatment (TPT) - given to high-risk individuals (PLHIV, household contacts, immunosuppressed)
- Prevention of transmission through infection prevention and control (IPC) measures
- BCG vaccination of children
Skin test/IGRA-negative contacts <5 years of age exposed to infectious cases are also candidates for TPT. (Harrison's, 22E)
b) Active Case Finding (ACF)
Campaign mode ACF is conducted in high-risk populations:
- Tribal populations
- Urban slums
- Old-age homes, prisons, orphanages
- Transit camps
- Priority districts based on TB burden, HIV-TB co-infection, DR-TB prevalence
c) Universal Drug Susceptibility Testing (DST)
- CBNAAT (GeneXpert) scaled to over 1,180 sites covering all districts
- ~55% of notified TB cases offered universal DST (as of Q3 2019)
d) Drug-Resistant TB Management
- Services initiated in Gujarat and Maharashtra in 2007, scaled nationally by 2013
- Shorter MDR-TB regimens and Bedaquiline-containing regimens introduced in 2018
- All-oral H mono/poly DR-TB regimens, shorter MDR-TB regimens, all-oral longer MDR-TB regimens available
e) Nikshay - Digital Surveillance Platform
- Integrated digital platform for case notification to treatment outcome
- All events (diagnosis, notification, treatment initiation, outcome) recorded
- Integrated with DVDMS for drug supply chain management
- Enables real-time monitoring at all levels
f) Ni-kshay Poshan Yojana
- Nutritional support of Rs 500 per month to all notified TB patients
- Addresses the social determinant of undernutrition which is both a risk factor and consequence of TB
12. COVID-19 Impact and Mitigation (Context of Disruption)
COVID-19 significantly disrupted TB services:
- TB notifications fell >50% between end of March and late April 2020 in India following national lockdown
- Reallocation of NTP staff, GeneXpert machines, and funding to COVID-19 response
- Reduced outpatient visits for DS-TB and MDR/RR-TB
Mitigation strategies adopted:
- Providing TB patients with at least a 1-month supply of anti-TB drugs
- Home delivery of drugs
- Enabling household members to collect drugs
- Expanded remote digital support
(Park's, p. 237)
13. Community Medicine Framework - How End TB Maps to Core Public Health Principles
| Public Health Principle | End TB Strategy Application |
|---|
| Epidemiological surveillance | Nikshay platform, drug resistance surveillance (DRS) |
| Health systems | NTEP organogram, universal health coverage, PHI engagement |
| Social determinants | Ni-kshay Poshan Yojana, social protection, poverty alleviation |
| Primary, secondary, tertiary prevention | BCG + TPT (primary), early diagnosis + ACF (secondary), treatment + rehabilitation (tertiary) |
| Community participation | Strong coalition with civil society; community engagement as NSP strategy |
| Intersectoral coordination | Multi-sectoral: social protection, labour, immigration, justice sectors |
| Health equity | Reaching tribal, slum, prison, migrant populations through ACF |
| Research & evidence | New tools: vaccines, shorter regimens, LTBI diagnostics |
14. Recent Evidence (2024-2026)
- A 2025 review on India's TB elimination strategies (Shah H et al., IJID Regions, 2025; PMID 39866845) specifically analyzed current strategies and areas for improvement in TB preventive treatment (TPT) - confirming TPT scale-up as a priority endgame intervention.
- A 2025 review on the Western Pacific Regional Framework (Oh KH et al., IJTLD Open, 2025; PMID 39959399) provides critical reflection on regional End TB implementation - underscoring that adapting the global End TB Strategy to country contexts is essential for success.
15. Summary - The Endgame Logic
The "endgame" for TB requires thinking beyond standard DOTS-era treatment toward:
- Finding the missed millions - active case finding, universal DST, private sector engagement
- Treating LTBI - TPT to prevent the reservoir of infected individuals from becoming cases
- New tools - post-exposure vaccines, shorter regimens, point-of-care LTBI tests
- Social protection - eliminating catastrophic costs, nutritional support
- Digital innovation - Nikshay, AI-based tools, telemedicine for adherence
- Political commitment - high-level government stewardship at national and state level
- Multi-sectoral action - addressing poverty, undernutrition, and social determinants
The End TB Strategy is a 20-year programme (2016-2035) that represents the most ambitious and comprehensive attempt in history to move TB from epidemic disease toward elimination. India's NTEP, with its DTPB framework and NSP 2017-2025, operationalizes this global strategy with country-specific adaptations and a target five years ahead of the SDG deadline.
Key References:
- Park's Textbook of Preventive and Social Medicine (Latest ed.), pp. 233-238, 482-488 - TB Chapter and NTEP Chapter
- Harrison's Principles of Internal Medicine, 22nd Ed. (2025), TB Preventive Treatment section
- WHO End TB Strategy (World Health Assembly, 2014)
- PAHO/WHO: Implementing the End TB Strategy - The Essentials (2016)
- Shah H et al. "Advancing tuberculosis elimination in India." IJID Reg. 2025. PMID: 39866845
- Oh KH et al. "The Western Pacific Regional Framework to End TB." IJTLD Open. 2025 Feb. PMID: 39959399